The objective is to validate a psychotherapeutic group protocol of dance as therapy created by LOBA association with a comparative non-randomized study.
This present research is a prospective longitudinal monocentric comparative study of an alternative, non-pharmacological therapy. It is a controlled, non-randomized, and experimental study in which half of the participants benefit from an additional program with speech and movement co-therapy via body activity, and the other half only benefit from standard support (e.g. medical, social, and legal assistance, individual psychotherapy). The effect of this program will be examined across three dimensions: * A clinical trial of N=80 participants to compare symptom improvement between individuals receiving the standard support for victims of sexual violence (N=40) and those receiving, in addition, the RECREATION program (N=40). * A longitudinal evaluation of physiological conditions, psychological traits, and social well-being of RECREATION workshop attendees (N=10) versus victims not participating in said workshops (N=10). * A qualitative analysis of interviews with program participants and their associated professionals (data saturation sample size).
Study Type
OBSERVATIONAL
Enrollment
65
Dance as therapy program with speech and movement co-therapy via body activity.
LOBA
Paris, France
Rate of participants presenting an improvement in PCLS scores at 6 months
Posttraumatic stress disorder checklist (PCLS) scores range from 0 to 85; a higher score means a worse outcome.
Time frame: 6 months period between January 2022 and April 2024
Rate of participants presenting an improvement in DASS-21 scores at 6 months
Depression, Anxiety, and Stress Scale in 21 (DASS-21) items scores range from 0 to 63; a higher score means a worse outcome.
Time frame: 6 months period between January 2022 and April 2024
Rate of participants presenting an improvement in QSCPGS scores at 6 months
Body satisfaction and global self-perception questionnaire (QSCPGS) scores range from -100 to +100; a higher score means a better outcome
Time frame: 6 months period between January 2022 and April 2024
Rate of participants presenting an improvement in SF-36 scores at 6 months
Short Form Health Survey in 36 items (SF-36) scores range from 0 to 100; a higher score means a better outcome
Time frame: 6 months period between January 2022 and April 2024
Rate of participants presenting an improvement in SSQ6 scores at 6 months
Social Support Questionnaire in 6 items (SSQ6) scores range from 0 to 54 for the availability subscale and from 6 to 36 for the satisfaction subscale. For both subscales, a higher score means a better outcome
Time frame: 6 months period between January 2022 and April 2024
Rate of participants presenting a change in RSQ score at 6 months
Relationship Scales Questionnaire (RSQ) scores give an attachment profile, attachment strategies and a self and other model.
Time frame: 6 months period between January 2022 and April 2024
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Rate of participants presenting an improvement in RFQ8 score at 6 months
Reflexive Functioning Questionnaire in 8 items (RFQ8) scores range from 0 to 18; a higher score means a worse outcome.
Time frame: 6 months period between January 2022 and April 2024
Number of participants presenting an improvement in Rorschach protocol at 1 year
Rorschach protocols are interpreted both qualitatively and quantitatively (psychogram). This outcome focuses on trauma symptomatology.
Time frame: A year between April 2022 and December 2023
Number of participants presenting an improvement in AAI scores at 1 year
Adult Attachment Interview (AAI) scores range from 0 to 90; a higher score means a better outcome.
Time frame: A year between April 2022 and December 2023
Number of identical themes in participants' and professionals' semi-structured interviews
Number of identical themes in participants' and professionals' semi-structured interviews
Time frame: One interview per person between September 2022 and March 2023